Nanomedicine Global Market Report 2022 – Yahoo Finance

Kevin Heal and Stephen Bigger break down potential benefits of rate hikes on financial stocks Wed, March 9 at 2 p.m. ET.
Major players in the nanomedicine market are Pfizer Inc. , Nanotherapeutics Inc. , NanoViricides Inc, Arrowhead Research Inc. , Celgene Corporation, Bio-Gate AG, Merck AG, Ablynx NV, F. Hoffmann-La Roche AG, Nanospectra Biosciences and GE Healthcare.
New York, March 03, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report "Nanomedicine Global Market Report 2022" – https://www.reportlinker.com/p06241915/?utm_source=GNW

The global nanomedicine market is expected to grow from $221.12 billion in 2021 to $252.50 billion in 2022 at a compound annual growth rate (CAGR) of 14.2%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $414.97 billion in 2026 at a CAGR of 13.2%.

The nanomedicine market consists of sales of nanotechnology-based applications in medicines by entities (organizations, sole-trader, and partnerships) that are engaged in utilizing nanomaterials for the enhanced diagnosis and treatment of various health issues.Nanomedicine is a branch of medicine that applies nanotechnology knowledge and tools for the prevention and treatment of disease.

They are nanoscale materials that are used in diagnosis and treatment procedures in oncology, cardiology, infectious diseases, orthopedics, and other medical areas.
Nanomedicine is an important instrument that enables personalized, targeted, and regenerative medicine by delivering improved new drugs, treatments, and implantable devices to clinicians and patients.

The main types of nanomedicine are nanoparticles, nanoshells, nanotubes, nanodevices, and others.Nanoparticles are a type of ultrafine particles usually between 1 and 100 nanometers in diameter used in making medicine and drugs.

The different forms of modality include diagnostics, treatments and are used in clinical oncology, infectious diseases, clinical cardiology, orthopedics, others.

North America was the largest region in the nanomedicine market in 2021.Asia Pacific is expected to be the fastest-growing region in the forecast period.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The rising burden of complex and chronic diseases across the globe is expected to contribute to the growth of the nanomedicine market in the forecast period.Nanomedicine is increasingly being used in treating chronic diseases including cardiovascular disorders, diabetes, cancer, dementia, and others where it helps in the fast metabolism of drugs in the body.

According to the international federation of Alzheimer’s associations, Alzheimer’s Disease International, more than 50 million people are suffering from dementia globally, and is projected to double every 20 years, which will reach 80 million by 2030 and 152 million by 2050. In 2020, the total cancer burden in the world increased to 19.3 million new cases and is predicted to rise to 28.4 million new cancer cases in 2040. This increasing burden of chronic diseases is expected to propel the demand for effective therapeutics treatment based on nanomedicine, thus driving the market.

The 4D Nanomedicine is a key trend gaining popularity in the nanomedicine market. 4D nanomedicine is used in medical procedures for safer treatment with nanoparticles. 4D nanomedicine is made with biodegradable and biocompatible nanoalloys that do not accumulate in the body, thus, limiting the side effects. The 4D nanomedicine is accepted as a fundamental development in the treatment and diagnosis of cancer. For instance, in 2020, a research team from the Department of Chemical Sciences, University of Padua investigated and confirmed the effectiveness of inorganic 4D nanoparticles in the biomedical field. 4D nanomedicine offers several advantages to the biomedical field including reduced side effects in a living organism, minimal environmental impact, improved quality of care, and spontaneous effect.

In November 2019, Bristol-Myers Squibb (BMS), a US-based pharmaceutical company completed the acquisition of Celgene for $74 billion.Under this acquisition, Celgene will be a wholly-owned subsidiary of BMS and Bristol-Myers Squibb plans to expand its range of innovative medicines.

Celgene is a US-based biopharmaceutical company that focuses on improving the lives of patients through innovative therapies using nanomedicine and nanotechnology.

The countries covered in the nanomedicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

Read the full report: https://www.reportlinker.com/p06241915/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

The idea of paying $5 a gallon for gas scares most Americans — at least the ones who don't live in California, where AAA reports that the price per gallon for gas currently sits at $5.07. "Because the cost of crude oil accounts for about 52% of retail gasoline's final cost, the price of gasoline generally follows movements in crude oil prices, which followed a similar price path during 2019." Crude oil prices have, of course, been rising and they could climb even higher due to Russia's invasion of Ukraine.
Three Motley Fool contributors took at look at some biotech stocks that could make you richer in March (and beyond). Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Novocure (NASDAQ: NVCR), and Vertex Pharmaceuticals (NASDAQ: VRTX). Prosper Junior Bakiny (Axsome Therapeutics): With a market cap of about $1.2 billion, Axsome Therapeutics qualifies as a small-cap stock.
Producers like EQT, Chesapeake Energy, and Coterra Energy stand to benefit from growing energy demand.
(Bloomberg) — Shell Plc, Europe’s largest oil company, bought a cargo of Russia’s flagship crude at a record discount, underscoring the company’s decision to keep buying supplies from the country after its invasion of Ukraine.Most Read from BloombergUkraine Update: U.K. Premier Says More Pressure Needed on PutinPutin Aims to Avert Defaults With Ruble Payment to CreditorsPutin Warns Ukraine as Safe-Passage Plans Descend Into ChaosUkraine Update: UN Council to Meet, Safety Corridors Set UpRussia
Elon Musk voiced an unusual stance for an electric-vehicle executive on Friday. Tesla Inc.’s (TSLA) chief executive said the U.S. needs to immediately increase production of oil and gas in a tweet late Friday, which runs against the grain of the EV maker’s own green-energy business initiatives. “Hate to say it, but we need to increase oil & gas output immediately,” Musk tweeted Friday.
Amid an investigation into a Cleveland-area extermination company, the Ohio Department of Agriculture has issued a public health alert for local residents who have used the company for the treatment of rodents after allegations of the company's misuse of rodenticides.
Silver prices move higher amid growing supply concerns over precious metals.
"We don't know what exactly is going on," Jenna Jameson tells her followers.
Gas prices are hitting $5 per gallon in places like San Francisco due to Russia's attack on Ukraine. Sanctions could result in a ban on Russian oil.
Boeing Co has preliminary plans to boost production of its cash cow 737-family narrowbody to around 47 per month by the end of next year, as the U.S. planemaker looks to extend its recovery from successive crises, two people familiar with the matter said. After slashing production due mainly to the pandemic, Boeing and European rival Airbus SE are seeing more demand for their medium-haul passenger jets, with both planemakers adding eye-catching deals to their order books in recent weeks. Boeing's production plans shift and are influenced by many factors, the people cautioned.
Not only did unemployment explode early on in the health crisis, but these days, a lot of households are struggling to make ends meet due to raging inflation. The good news, though, is that there are new antiviral pills available that could reduce COVID-19 symptom severity and, in some cases, reduce the likelihood of a diagnosed patient needing hospitalization.
There is a sobering new study about the long-term effects of alcohol on your brain; Bradley Blackburn reports for CBS2.
The main airline ETF has slumped 16% since Feb. 14. Its biggest holdings are Delta Air, United, Southwest and American.
(Bloomberg) — Elon Musk says more fossil fuel production is needed now, even if it’s bad for his electric car company, Tesla Inc. Most Read from BloombergUkraine Update: U.K. Premier Says More Pressure Needed on PutinPutin Aims to Avert Defaults With Ruble Payment to CreditorsPutin Warns Ukraine as Safe-Passage Plans Descend Into ChaosUkraine Update: Blinken Says U.S., Allies Discussing Oil EmbargoUkraine Update: UN Council to Meet, Safety Corridors Set Up“Hate to say it, but we need to increas
Palladium remains sensitive to Russia’s invasion of Ukraine, which could disrupt production and raise prices for the metal.
It's no secret that family restaurants were hard hit by the pandemic. Friendly's was edged into bankruptcy in late 2020 and Denny's lost an incredible 60% of its customers in 2021. Even the Cheesecake Factory took a tumble, struggling to pay its rent.But amidst all of the commotion in the past two years, you might have missed some important developments at one of America's longest-running family chains: Marie Callender's. The beloved, California-based restaurant and bakery chain seems to be disa
The actress best known for playing Lavender Brown says COVID-19 has hit her "like a ton of bricks for weeks."
It's been two years since COVID-19 caused the world to shut down, people to isolate, and for parts of society to change permanently. Since March 2020 there has been significant progress made with highly effective vaccines and boosters available to the public, and COVID cases are thankfully dropping. But virus experts are not unanimous on being out of the woods just yet. "We look to a future when Americans no longer fear lockdowns, shutdowns, and our kids not going to school," says The White Hous
An electric vehicle maker considered – and then rejected – North Carolina for a 7,500-job manufacturing plant. It likely came down to politics.
It was in vain that Sen. Lauren Book shared her painful experience of being drugged and raped by several men as a young teen. Her powerful testimony on the Florida Senate floor — the first time she shared it publicly — fell on deaf ears.

source

Leave a Comment

Your email address will not be published.

Shopping Cart